Analytical Data
-
基因名
KYAT1
- Application
-
别名
KYAT1；CCBL1；Kynurenine--oxoglutarate transaminase 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q16773
-
表达区间
1-372aa
-
氨基酸序列
MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFMLNQYTKTFVIIIEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVLNTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTLTIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFRQPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDEPYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKVEL
-
分子量
58.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human CHCHD8 Protein，His
Cat：PA2000-6672
Recombinant Human SCIN Protein，His
Cat：PAX2000-11150
Recombinant Human S100A5 Protein，His
Cat：PA1000-6854
Recombinant E.coli FCY1 Protein，His
Cat：PA2000-3025
Protein Description
KYAT1, or Kynurenine Aminotransferase 1, is an important enzyme involved in the metabolism of tryptophan, a critical amino acid that impacts various physiological processes, including mood regulation, neuroprotection, and immune response. Research into KYAT1 has gained significant attention due to its role in the kynurenine pathway, which produces metabolites that can influence neuroinflammatory conditions and neurodegenerative diseases. Recent studies have associated dysregulation of KYAT1 activity with disorders such as depression, schizophrenia, and Alzheimer's disease, suggesting its potential as a therapeutic target. The recombinant expression of KYAT1 protein allows for detailed structural and functional studies, facilitating the understanding of its enzymatic properties and interactions with other metabolites. Such research may contribute to the development of novel treatments for psychiatric and neurological disorders by manipulating the kynurenine pathway. Understanding KYAT1's role at the molecular level can also illuminate its involvement in broader metabolic networks and help identify biomarkers for disease diagnosis and progression. Overall, the study of KYAT1 recombinant protein represents a promising avenue for advancing our knowledge of tryptophan metabolism and its implications for mental health and neurodegenerative diseases.
